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Abstract 
CD4+ T cells play a critical role in the immune system and protecting the body 
from infection. Cell differentiation of T-cells leads to the specialization of the immune 
system and has been determined to have plasticity. Differentiation of the CD4+ T cells 
depends on cytokines present in the environment, concentration of antigens, types of 
antigen – presenting cells (APCs), and costimulatory molecules (Luckheeram, 2012). 
Commonly known differentiated T-cells include the T-helper 1 (Th1) and the T-helper 2 
(Th2) cells. Upon CD4+ T cell activation, the cells undergo metabolic changes that allow 
for cell growth and division. By characterizing the metabolic network of these cells, we 
gain a better understanding of metabolic processes that are characteristic of each cell 
type. Expression data was gathered and used to identify essential genes within the 
differentiated cells. With statistical analysis of these cell’s gene expression and 
regulation, we can more fully understand each gene that plays a role in the 
differentiation of the naïve cell. Specifically, I will focus on the differentiation of Th2 cells 
from the naïve CD4+ T cell. With computational modeling, the metabolic network of Th2 
cells was built.  
 
Key Words: T-helper 2 Cell, CD4+ T Cells, Metabolic Network Model, Constraint-Based 
Modeling, Flux Balance Analysis, Biochemistry  
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Introduction 
 CD4+T cells  
The immune system is critical for the body to fight off pathogens and protect the 
body from disease. It is comprised of lymphocytes, which allow these functions to be 
carried out (Janeway, 2001). More specifically, T- lymphocytes mature in the thymus 
gland and are designed to send out signals to other cells to localize and eradicate a 
foreign pathogen (Janeway, 2001). T – lymphocytes consist mainly of CD4+T and 
CD8+T cells. CD4+ T cells function in recognition and elimination of foreign antigens, 
formation of immunologic memory, and development of tolerance to self-antigens 
(Luckheeram, 2012). Upon activation, CD4+ T cells can send out signals through 
secreted cytokines, which in turn have the ability to activate various pathogen fighting 
cells (Janeway, 2001). The cells could be of the innate immune system, B-lymphocytes, 
cytotoxic T cells, and nonimmune cells (Luckheeram, 2012). They also play a role in 
suppression of immune reaction (Luckheeram, 2012). There are two commonly known 
CD4+ T cell subtypes; T-helper 1 (Th1) and T- helper 2 (Th2) cells. Other CD4+ T 
subtypes have been identified and include T-helper 17 (Th17), follicular helper T cell 
(Tfh), induced T regulatory cells (iTreg), regulatory type 1 cells (Tr1) and T-helper 9 
(Th9) (Luckheeram, 2012). Loss of CD4+ T cell function results in compromised 
immune system, making the individual more susceptible to disease (Zhu, 2010).  
 
T Cell Activation 
For a T cell to differentiate, it must first become activated. In order to become 
fully activated, the cell must complete three distinct activation signals (Goral, 2011). The 
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three-signal hypothesis explains the necessary signals. T cell activation begins when an 
antigen-presenting cell (APC) is introduced to an antigen (Roche, 2015). The APC 
causes the foreign pathogen to be endocytosed and cleaved (Roche, 2015). Class II 
major histocompatibility complex (MHCII) presents a portion of the antigen that a CD4+ 
T cell can then bind to. TCR and CD4 interaction with antigen-MHC II complex causes 
antigenic stimulation (Goche, 2015). This is the first signal. TCR signaling induces a 
network of downstream signaling that promote naïve cell proliferation and differentiation 
into subtype lineages (Luckheeram, 2016). Costimulatory response is the required for 
cell activation and is considered signal 2 (Goral, 2011). Costimulation of the T cell 
occurs by APCs interaction with CD28. Signals provided by inflammatory cytokines are 
required for an effective T Cell response, so cytokine signaling is signal 3 (Goral, 2011).  
Naïve cells are then able to transform into specific T cell subtypes based on the 
environmental factors. The Th2 cell is responsible for coordinating response to large 
extracellular pathogens (Luckheeram, 2012).  
Once T Cells have been activated, there is switch in metabolism for the cell 
which can be referred to as metabolic reprograming (Almedia, 2016). Naïve cells are 
quiescent, meaning they are not dividing, until receiving the activation signals (Pearce, 
2013). The activation of the T cell requires a metabolic shift for the cell to grow and 
divide (Almedia, 2016). Shifts in metabolism can be seen in a variety of areas. There is 
an increased flux in glycolysis, glutaminolysis, pentose phosphate pathway, and the 
hexoamine pathway (Almedia, 2016). There is a strong increase in glucose uptake, 
making glucose readily available within the cells (Palmer, 2015).  Naïve cells exhibit 
oxidative phosphorylation, but activation results in aerobic glycolysis, also known as the 
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Warburg Effect. The Warburg Effect is when the cell relies on glycolysis followed by 
lactic acid fermentation as it’s source for energy (Pearce, 2013). Also, there is a switch 
from fatty acid metabolism to fatty acid synthesis (Almedia, 2016). Fatty acids are basic 
components of the plasma membrane and required when the cell is growing and 
dividing.   
 
Th2 Differentiation 
Differentiation refers to the process by which a cell develops into specialize 
subset of a specific cell allowing it to perform unique functions (Luckheeram, 2012). 
Differentiation is influenced by environmental factors present, such as cytokines and 
transcriptional factors (Luckheeram, 2012). For Th2, GATA3 is a transcription factor that 
is the master regulator (Zhu, 2010). Without the presence of this transcriptional factor, 
Th2 cells would not develop. In the absence of GATA3, naïve cells are diverted to Th1 
cells (Zhu, 2010). Naïve cells in the presence of GATA3 are also responsible for the 
suppression of Th1 differentiation by downregulating STAT4 (Zhu, 2010). Other 
transcriptional factors that influence the differentiation of Th2 cells include STAT6, 
STAT5, STAT3, Gfi-1, c-Maf, IRF4 (Jetten, 2009). GATA3 alone cannot form Th2 cells 
(Zhu, 2012). The master regulator needs collaboration, specifically with STAT6. As 
mentioned, cytokines play an influential role in the development of Th2 cells (Zhu, 
2010). Important cytokines for Th2 differentiation include IL4 and IL2 (Jetten, 2009). IL2 
activates STAT5 (Jetten, 2009).  
Everything mentioned so far, helps with the development of Th2 cells, but there 
are also elements that can prevent the differentiation of Th2 cells. Inhibitory 
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transcription factors include T-bet and Runx3 (Zhu, 2010). Naïve cells in the presence 
of these inhibitory transcription factors will prevent Th2 cells from developing (Zhu, 
2010). Instead, the naïve cell will be diverted to another type of specialized T-cell. As 
mentioned early, a metabolic reprogramming occurs when the T cells are activated. The 
transcription factors mentioned are unique to each specific cell subtype and contribute 
to the overall metabolism of the cell.  
 
Computational Modeling 
Computational models are built using experimental data, as well as known 
characteristics of in vivo and in vitro systems. These models can be used to run 
simulations that represent hypothetical situations. The simulations can lead to 
predictions or hypotheses that can be tested with further simulations and experimental 
data. Computational modeling aims to replicate a system based on known properties of 
the system’s components (Brodland, 2015). Metabolic processes have a fundamental 
role in many important aspects of human health. These processes are vastly complex 
and the large number of cellular components and interactions can be hard to interpret. 
Computational modeling is a way to make sense of these complex systems. These 
models are based on conceptual, mathematical and algorithmic assumptions (Brodland, 
2015). It allows the user to change environmental factors and observe their affects.  
Constraint based modeling is a type of computational modeling. It is a 
mathematical technique in which the outputs are limited based on a maximum and 
minimum limit, or constraint (Haggart, 2011). This type of modeling is often paired with 
optimization to determine the most optimal solution of an objective under the given 
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constraints. Constraints reduce the possible solutions and allow for more accurate 
predictions. Constraint based modeling is common technique used to create metabolic 
network models. In metabolic network modeling, there are four commonly used 
constraints. They include physico-chemical constraints, environmental constraints, 
spatial/topological constraints, and self-regulatory constraints (Haggart, 2011). 
More specifically, Flux Balance Analysis (FBA) is a type of constraint-based 
modeling and will be used in the construction of the Th2 metabolic network. It is an 
approach that analyzes flow of metabolites through a metabolic network based on 
mathematics (Orth, 2010). This method allows for the prediction of growth rate and rate 
of production of important metabolites (Orth, 2010). The metabolic network will contain 
all known metabolic reactions in the organism and genes that code for each enzyme. 
FBA predicts the flux profile that optimizes a defined objective without experimental 
measurements (Orth, 2010). It assumes that cellular metabolism is in a steady-state 
and uses linear programing to the determine the flux-profile that optimizes the 
organism’s objective function (Orth, 2010). Typically, the objective is biomass 
production and that is what the objective will be for the Th2 metabolic network.  
The program MatLab will be used to construct the Th2 metabolic network model. 
Recon2.2.05, an extensive map of all genes in the human genome, will be used as the 
seed model upon which the Th2 model will be created. Recon2.2.05 is the most 
representative model of human metabolism to date (Swainston, 2016). It differs from 
previous versions in that there have been significant updates to respecification of fatty 
acid metabolism, oxidative phosphorylation and a coupling of the electron transport 
chain to ATP synthase activity (Swainston, 2016). The model was developed through a 
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combination of manual and automated error checking. This version of the model 
contains 5324 metabolites, 7785 reactions, and 1675 associated genes (Swainston, 
2016).  
 
Methods  
Obtaining Expression Data Sets 
Gene Expression Omnibus (GEO), a public data base containing gene sets, was 
used to search for untreated differentiated Th2 cells. When searching for datasets, 
unpolarized subtype conditions and subtype controls were accepted and used in the 
model. Knock out and treated cells were excluded from sample gathering. Both 
technical and biological replicates were used in the construction of the models. Three 
types of expression datasets were included in the models. These platforms were 
Affymetrix, Agilent, and Proteomics. A complete list of samples can be found in Table 1. 
 
Th2 Samples (37) 
Sample Source Treatment Time Replicate 
GSM60357 cord blood CD4+ cells antiCD3+andtiCD28+IL4 2 hours 1a 
GSM60358 cord blood CD4+ cells antiCD3+andtiCD28+IL4 6 hours  1a 
GSM60362 cord blood CD4+ cells antiCD3+andtiCD28+IL4 48 hours 1b 
GSM60368 cord blood CD4+ cells antiCD3+andtiCD28+IL4 48 hours 2b 
GSM60373 cord blood CD4+ cells antiCD3+andtiCD28+IL4 6 hours 2a 
GSM60379 cord blood CD4+ cells antiCD3+andtiCD28+IL4 2 hours 2a 
GSM60708 cord blood CD4+ cells antiCD3+andtiCD28+IL4 2 hours 1a 
GSM60709 cord blood CD4+ cells antiCD3+andtiCD28+IL4 6 hours 1a 
GSM60713 cord blood CD4+ cells antiCD3+andtiCD28+IL4 48 hours  1b 
GSM60719 cord blood CD4+ cells antiCD3+andtiCD28+IL4 48 hours  2b 
GSM60724 cord blood CD4+ cells antiCD3+andtiCD28+IL4 6 hours 2a 
GSM60730 cord blood CD4+ cells antiCD3+andtiCD28+IL4 2 hours 2a 
GSM60742 cord blood CD4+ cells antiCD3+andtiCD28+IL4 2 hours  1a 
GSM60743 cord blood CD4+ cells antiCD3+andtiCD28+IL4 6 hours  1a 
GSM60747 cord blood CD4+ cells antiCD3+andtiCD28+IL4 48 hours 1b 
GSM60753 cord blood CD4+ cells antiCD3+andtiCD28+IL4 48 hours 2b 
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GSM60758 cord blood CD4+ cells antiCD3+andtiCD28+IL4 6 hours  2a 
GSM60764 cord blood CD4+ cells antiCD3+andtiCD28+IL4 2 hours  2a 
GSM565281 CD4+ t cells, PBMC aCD3/aCD28 12 hours 1 
GSM565282 CD4+ t cells, PBMC aCD3/aCD28 12 hours 2 
GSM565283 CD4+ t cells, PBMC aCD3/aCD28 12 hours 3 
GSM565284 CD4+ t cells, PBMC aCD3/aCD28 48 hours 1 
GSM565285 CD4+ t cells, PBMC aCD3/aCD28 48 hours 2 
GSM565286 CD4+ t cells, PBMC aCD3/aCD28 48 hours 3 
GSM565998 CD4+ t cells, PBMC aCD3/aCD28 12 hours 1 
GSM565999 CD4+ t cells, PBMC aCD3/aCD28 12 hours  2 
GSM566000 CD4+ t cells, PBMC aCD3/aCD28 12 hours 3 
GSM566001 CD4+ t cells, PBMC aCD3/aCD28 48 hours 1 
GSM566002 CD4+ t cells, PBMC aCD3/aCD28 48 hours  2 
GSM566003 CD4+ t cells, PBMC aCD3/aCD28 48 hours  3 
GSM1070756 naïve CD4+ t cells 
isolated from 
peripheral blood 
Activated with 
PMA/Ionomycin for 4 hours 
28 days 1 
GSM1070760 naïve CD4+ t cells 
isolated from 
peripheral blood 
Activated with 
PMA/Ionomycin for 4 hours 
28 days 2 
GSM1070764 naïve CD4+ t cells 
isolated from 
peripheral blood 
Activated with 
PMA/Ionomycin for 4 hours 
28 days 3 
GSM1054776 Whole blood   2 
GSM1054784 Whole blood   3 
GSM1054788 Whole blood   1 
GSM1054792 Whole blood   4 
Table 1: Th2 Samples 
A summary of the thirty-seven samples used to create the Th2 metabolic model is 
contained in the table. Sample name, source, treatment, replicate can be found on the 
table.  
 
 
Expression Data Analysis 
Affymetrix data was analyzed by downloading the raw expression sets from the 
GEO database or from the literature. Using the Affy package in R, MAS5.0 
normalization was applied to the data to compensate for systematic technical 
differences between chips. Through normalization, expression of a probes was 
designated as present, marginal or absent. These are referred to as PMA calls. A 
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present or marginal signal represents an active gene. An absent signal represents an 
inactive probe. A probe was considered active if at least half of the samples for the 
probe were deemed active. A probe was determined to be inactive if less than half of 
the samples for the probe were deemed active. Affymetrix datasets used in the model 
were GSE2770, GSE22886, and GSE43769.  
One Agilent dataset, GSE43005, was used to create the metabolic network 
model. This dataset was quantile normalized and averaged over the four biological 
replicates. A control probe was used in this experiment. The average expression of the 
four samples for a single probe was compared to the average expression for the control 
probe. If the expression level was greater than the control, then the probe was 
considered active. If the expression level fell below the level of the control, the probe 
was marked as inactive.  
A proteomics data set was obtained from literature. Genes of measured proteins 
were deemed active if at least half the samples had a protein count greater than zero. 
Genes of proteins were deemed inactive if at least half the samples had no protein 
counts present.  
 
Final Expression Determination 
 The final expression for the genes was determined by combining all datasets. To 
do this, R was used to combine the expression sets into one dataset containing all 
probe ids and samples from the microarray data. Probe ids were converted into HGNC 
ids. Samples had been previously marked with a one or zero; one indicating active and 
zero indicating inactive genes. For each HGNC id, the samples were averaged. If the 
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average across the samples was greater than 0.5, the gene was considered active. If 
the average was less than 0.5, then the gene was inactive.  
The active probes in the microarray and proteomics data were compared. The 
overlapping genes between the two types of data are considered high-confidence active 
genes. These are used in the final model. The same process was used to determine 
inactive genes used in the model. To further curate the data and account for genes that 
may not have been measured in the microarray data or vice versa, further analysis of 
both proteomics and microarray data was conducted. For the proteomics data, the 
average raw count for each HGNC id was calculated across the four samples. Using the 
quartile function, genes with the protein counts in the 75th percentile were determined. 
These genes were considered active regardless of whether they overlapped with the 
microarray. Genes in the 25th or lower percentile were considered inactive and added to 
the final model. For the microarray data, genes from the non-overlap between 
microarray and proteomics with 90 percent or greater active samples were added as 
active genes to the final model. Microarray genes from the non-overlap area with 10% 
or less active samples were added to the model as inactive genes. The final expression 
matrix consisted of HGNC ids represented as active (1) or inactive (0). These 
expression values were then used to create the metabolic model.  
 
Metabolic Network Model Generation  
 The metabolic model was created using the COBRA Toolbox in Matlab. The 
function createTissueSpecificModel was used for model construction. Recon2.2.05 was 
used as the seed model and the matrix created from the microarray and proteomics 
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data was used as the expression data. The removeDeadEnds function was used to 
remove any unnecessary metabolites and reactions. The model was then ready for 
further analysis.  
 
Validation of Model 
 The model was further analyzed to determine its validity. These validations 
included determination of the biomass function, gene essentiality, flux through major 
metabolic pathways, and model response to removal of glucose or glutamine. Using the 
function optimizeCbModel, the biomass function was determined. This value was 
compared to published values for humans to see if the results aligned. Gene essentiality 
was determined in the model with the function [GrRatio, GrRatioKO, grRatioWT, 
delRxn, hasEffect] = singleGeneDeletion(model). Cobra solver gurobi was used. 
Essential genes in the model were compared to the essential genes of other human cell 
types. A list of essential human genes in other cell types has been published in the 
Online GEne Essentiality (OGEE) database. Flux through glycolysis, fatty acid 
synthesis, fatty acid oxidation, and the tricarboxylic acid cycle (TCA) pathways were 
determined. Lastly, removal of glucose or glutamine transport reactions was done using 
removeRxns(model, 'EX_gln_L(e)') for glutamine and removeRxns(model, 'EX_glc(e)') 
for glucose.  
 Validation had two outcomes; a functional or a nonfunctional model. A functional 
model had validation results that aligned with expected and known result of actual Th2 
cells. A nonfunctional model had validation results that were not what was expected. 
When it was determined that the model was nonfunctional, the model needed to be 
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edited. Models were edited to adjust them to the proper expected results. Model 
refinements included changing the biomass objective function, addition and removal of 
reactions, adjustment of reaction bounds, and fixing errors related to syntax.  
 
 
Results 
Final Gene Expression Determination 
 The final gene expression was determined by combining the expression datasets 
obtained from the GEO database. When comparing the active genes from the 
microarray data to the active genes from the proteomics data, there were 6619 active 
genes that overlapped. These genes were considered high-confidence active genes 
and were put into the final model (Fig. 1). Of the 958 proteomics genes that did not 
overlap with the microarray data, 149 were in the top 75th percentile of expression levels 
of all proteomics genes and added to the final model (Fig. 2). Looking at the microarray 
data, 6913 active genes did not overlap with the proteomics data. 103 of the non-
overlapping active microarray genes were in the top 10% of expression rates and added 
the final matrix (Fig. 3). As for inactive genes, 1378 genes were determined to be both 
inactive in the proteomics data and the microarray data (Fig. 4). Of the non-overlapping 
region, there were 833 inactive genes from the proteomics data that were in the bottom 
25th percentile and added to final model (Fig. 5). There were 2937 inactive genes added 
to the final model from the microarray data that represents the bottom 10% of 
expression levels (Fig. 6). Table 2 summarizes the matrix composition.  
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Figure 1: High Confidence Active Genes 
The active genes from the microarray data (Active Affy) were compared to the active 
genes from the proteomics data (Active Prot). The overlap represents genes that were 
active in both types of data and are considered high-confidence active genes.  
 
 
Figure 2: Added Active Proteomics Genes  
Active genes from the Proteomics data that did not overlap with the microarray data 
(Fig.1) were compared to the top 75th percentile of active proteomics genes. The 
overlap represents genes that are not present or active in the microarray but fall in the 
top 75th percentile of active gene in the proteomics data.  
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Figure 3: Added Active Microarray Genes 
Genes from the microarray data that did not overlap with the proteomics data (Fig.1) 
were compared to the top 10% of active genes from the microarray data. The overlap 
represents genes that were not present or active in the proteomics data but were in the 
top 10% of active microarray genes. 
 
 
 
 
Figure 4: High-Confidence Inactive Genes 
The inactive genes from the microarray data (Inactive affy) were compared to the 
inactive genes from the proteomics data (Inactive prot). The overlap represents genes 
that were not active in either of the two data sets and are considered high confidence 
inactive genes.  
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Figure 5: Added Inactive Proteomics Genes  
Inactive genes from the Proteomics data that did not overlap with the microarray data 
(Fig.3) were compared to the bottom 25th percentile of inactive proteomics genes. The 
overlap represents genes that are not present or inactive in the microarray data, but fall 
in the bottom 25th percentile of inactive gene in the proteomics data.  
 
 
 
Figure 6: Added Inactive Microarray Genes 
Genes from the microarray data that did not overlap with the proteomics data (Fig.1) 
were compared to the top 10% of active genes from the microarray data. The overlap 
represents genes that were not present or active in the proteomics data but were in the 
top 10% of active microarray genes. 
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Th2 Matrix Composition 
Active Genes in Both Microarray and 
Proteomics  
6619 
Active Proteomic Genes Added   149 
Active Microarray Genes Added  103 
Inactive Genes in Both Microarray and 
Proteomics  
1378 
Inactive Proteomics Genes Added  822 
Inactive Microarray Genes Added  2937 
Table 2: Th2 Model Composition 
This table summarizes the results of the Th2 Matrix used to construct the final model. 
Sources for the active and inactive genes are listed.   
 
 
Th2 Metabolic Model  
 The final Th2 model consisted of 1151 genes, 2601 metabolites, 4654 reactions. 
The biomass objective function was 1.7037/hour. Table 3 summarizes these results. 
Because the model was based off Recon2.2.05, all reactions, genes, and metabolites 
present in the Th2 metabolic network, were also present in the Recon2.2.05 metabolic 
model. Essentially, the Th2 metabolic model constructed represents a subset of the 
Recon2.2.05 model.  
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Th2 Model  
Genes 1151 
Metabolites  2601 
Reactions  4654 
Biomass Objective Function  1.7037/hour 
Table 3: Th2 Model Composition 
This table summarizes the results upon curation of the Th2 metabolic model. You can 
find number of genes, reactions, and metabolites, as well as the biomass objective 
function.  
 
 
 
Model Validations  
The model was analyzed to determine the validity. When model validations were 
consistent with what was expected, the model was considered valid. When the 
validations did not align with the expected outcomes, the model was considered 
nonfunctional. The nonfunctional models needed to be edited so that it would reflect the 
expected results. The Th2 metabolic model required a change in biomass objective 
function. The original biomass objective function was a series of functions for individual 
compartments. This was replaced with one biomass object function that was 
representative of the system. Change in the biomass objective function required the 
addition of reactions to support the new objective function and removal of reactions 
associated with old biomass objective function. The reaction bounds were changed for 
some of the reactions. This was due to some reactions being limited to only one 
reaction direction. Bounds were changed to allow forward and reverse direction. There 
were syntax errors in the model, which caused it to be nonfunctional. Correcting these 
errors was essential.  
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The model was first optimized, which resulted in a biomass reaction flux of 
1.7037/hr. This was determined to be within reason of an appropriate value for the Th2 
model. The biomass function is a representation of cell growth or biomass production. 
So, a biomass value of 1.7037 means the cell has a biomass production, or cell growth, 
of 1.7037 per hour.  
Next, gene essentiality was determined. It was determined that Th2 has 49 
essential genes. This was determined by looking at the knockout gene ratio. When the 
biomass value was decreased to zero, this indicated that the gene was essential 
because deletion of the gene resulted in no biomass production. The essential genes 
were then compared to essential genes in other human cell types. As mentioned earlier, 
a list of essential human genes was obtained from OGEE database. Of those 49 
essential Th2 genes, 38 of them were determined to be essential in other human cell 
types as well.  
Flux through the major metabolic pathways was next determined. Each reaction 
involved in glycolysis and the TCA cycle was checked. Flux through these pathways 
indicates flow of metabolites and the reactions in the pathways are active, or occurring. 
There was an overall flux through these pathways. Reactions associated with fatty acid 
synthesis and fatty acid oxidation were also determined to have flux through their 
pathways.  
Last, the glucose exchange reaction was removed from the model. This resulted 
in a decrease in the biomass flux reaction. The reaction decreased from 1.7037 
biomass production per hour to 1.5867 biomass production per hour. When glutamine 
was removed, a decrease in biomass flux reaction was also observed. The value 
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decreased from 1.7037 biomass production per hour to 1.6168 biomass production per 
hour.  
 
 
Discussion  
 We have successfully constructed a functional metabolic model for Th2. Upon 
analysis of the model, we can determine the validity of it. Looking at the biomass 
objective function serves an important function in determining the growth rate of an 
organism. Through flux balance analysis we can determine this. Flux balance analysis 
calculates the flow of metabolites through the metabolic network (Feist, 2010). It 
describes the growth requirements of a cell and can give insight to the cellular 
processes occurring within the cell. The Th2 model had a growth rate of 1.7037/hr. This 
means that the cell has a 0.587 hour doubling time. We considered these reasonable 
for a Th2 cell by comparing them to published growth rate values. A low biomass 
objective function would indicate low cell growth and biomass production. Because Th2 
cells are actively growing and dividing, this biomass function is expected.  
 We also looked at gene essentially within the Th2 model. The 
singleGeneDeletion function works by removing a single gene from the model and 
representing the result of deletion with a biomass objective function value. A decrease 
in this value indicates the gene’s importance to the model. A biomass value that drops 
to zero upon the deletion of a gene signifies that the model is unable to grow without 
that gene. Unchanged biomass function, indicates that when the gene was deleted 
there was no effect on the biomass production of the cell and that gene would not be 
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considered essential. The cell can still survive without that gene. It was determined that 
there were 49 essential genes specific to this model. When comparing those essential 
genes to the known essential genes in other human cell types, 38 of the 49, or 77.6%, 
genes were also essential in other human cell types. We expected there to be a high 
number of essential genes in our model that were also essential other human cells. 
Many of the essential metabolic pathways in other human cell types are also present in 
our model.  
Both glucose and glutamine are important for proper functioning of Th2 cells. 
Glucose is used for ATP generation. Glucose is transported into the cell by GLUT1, 
which is the major glucose transporter for T cells (Porter, 2015). Glucose becomes 
trapped inside the cell and is metabolized through glycolysis to produce pyruvate and 
two ATP molecules (Porter, 2015). Pyruvate can be further oxidized through the TCA 
cycle, which will fuel the oxidative phosphorylation pathway and produce 36 ATP 
molecules (Palmer, 2015). Glutamine is important for T cells activation and growth. After 
T-cell activation, glutamine catabolism is dramatically induced (Van der Windt, 2012). 
Glutamine can be used for glutaminolysis, to maintain homeostasis of TCA cycle or to 
generate NAD and NADH (Kouidhi, 2017). It can also be used during T cell activation to 
overcome intense aerobic glycolysis (Kouidhi, 2017). Glutamine can do this by providing 
pyruvate. Lack of glutamine can result in inhibition of cell growth, proliferation, and 
cytokine production (Palmer, 2015). The importance of glucose and glutamine to the 
Th2 model system can be demonstrated by observing the effect of removing either of 
these substrates from the model on the biomass objective function. Because both 
glucose and glutamine play crucial roles in Th2 cell metabolism, we would expect the 
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biomass objective function to be negatively affected. Upon removal of either from the 
cell, we observed a decrease in the biomass function. This indicates slowed growth, 
agreeing with what would be observed in nature. The reason we didn’t see the biomass 
objective function drop to zero upon removing glucose or glutamine is because there 
are other carbon sources available that the cell can use for metabolism.  
 Furthermore, glycolysis, TCA cycle, fatty acid synthesis, and fatty acid oxidation 
are important metabolic processes for a Th2 cell (Pearce, 2013). By analyzing these 
pathways, we can determine if the model is behaving in the way we expect it to. The 
individual reactions of each metabolic process were looked at to determine if there was 
flux. Flux indicated that the reactions were occurring. While not every reaction in the 
pathway had flux, every metabolic process had an overall flux signifying that the 
process was active. This is what we would expect and serves as further validation of the 
model. Lack of specific flux could indicate equilibrium of the specific reaction.  
 
 
Conclusion 
 We have constructed a Th2 specific metabolic model using gene expression 
data. The final model was built off Recon2.2.05 and contains 1151 genes, 2601 
metabolites, and 4654 reactions. As our team continues to do research, the model will 
become further validated. Eventually we hope to create a Th2 model that is true to how 
Th2 cells function in the human immune system. Naïve subtype cells Th1, Th17 and 
Treg have also been constructed. This type of model can give insights into how the 
immune system reacts to different pathogens, cytokines, and environmental stimulants 
by simulation of the model. These models have applications in education, technology, 
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and medicine. Eventually, we hope to use these models to look at differences between 
the subtype naïve cells to gain a better understanding of the unique metabolic 
processes associate with each subtype cell. Beyond furthering our own research, these 
models will be shared with the scientific community and can further the research of 
others.  
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